{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T04:08:40Z","timestamp":1795234120444,"version":"4.10.3"},"reference-count":24,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Beijing Science and Technology Commission","award":["D141100000114002"],"award-info":[{"award-number":["D141100000114002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108012"],"award-info":[{"award-number":["81820108012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870913"],"award-info":[{"award-number":["81870913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971614"],"award-info":[{"award-number":["81971614"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key R&D program of China","award":["2016YFC1307301"],"award-info":[{"award-number":["2016YFC1307301"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2021,3,26]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Studies show tranexamic acid can reduce the risk of death and early neurological deterioration after intracranial haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in intracerebral haemorrhage patients susceptible to haemorrhage expansion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We did a prospective, double-blind, randomised, placebo-controlled trial at 10 stroke centres in China. Acute supratentorial intracerebral haemorrhage patients were eligible if they had indication of haemorrhage expansion on admission imaging (eg, spot sign, black hole sign or blend sign), and were treatable within 8\u2009hours of symptom onset. Patients were randomly assigned (1:1) to receive either tranexamic acid or a matching placebo. The primary outcome was intracerebral haematoma growth (&gt;33% relative or &gt;6\u2009mL absolute) at 24\u2009hours. Clinical outcomes were assessed at 90 days.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 171 included patients, 124 (72.5%) were male, and the mean age was 55.9\u00b111.6 years. 89 patients received tranexamic acid and 82 received placebo. The primary outcome did not differ significantly between the groups: 36 (40.4%) patients in the tranexamic acid group and 34 (41.5%) patients in the placebo group had intracranial haemorrhage growth (OR 0.96, 95% CI 0.52 to 1.77, p=0.89). The proportion of death was lower in the tranexamic acid treatment group than placebo group (8.1% vs 10.0%), but there were no significant differences in secondary outcomes including absolute intracranial haemorrhage growth, death and dependency.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among patients susceptible to haemorrhage expansion treated within 8\u2009hours of stroke onset, tranexamic acid did not significantly prevent intracerebral haemorrhage growth. Larger studies are needed to assess safety and efficacy of tranexamic acid in intracerebral haemorrhage patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2021-000942","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T05:55:11Z","timestamp":1617256511000},"page":"160-169","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial"],"prefix":"10.1136","volume":"6","clinical-trial-number":[{"clinical-trial-number":"nct02625948","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-0267","authenticated-orcid":false,"given":"Jingyi","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-4076","authenticated-orcid":false,"given":"Ximing","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1608-1856","authenticated-orcid":false,"given":"Hongqiu","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Sun","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-9255","authenticated-orcid":false,"given":"Dacheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tangshan People\u2019s Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tangshan Gongren Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Luhe Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Pinggu Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijin","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liangxiang Hospital of Beijing Fangshan District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Sun","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Department of Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-055X","authenticated-orcid":false,"given":"Liping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-2341","authenticated-orcid":false,"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"2025081709413035000_6.2.160.1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.022618"},{"key":"2025081709413035000_6.2.160.2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5853\/jos.2016.00864","article-title":"Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update","volume":"19","author":"An","year":"2017","journal-title":"J Stroke"},{"key":"2025081709413035000_6.2.160.3","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2016-000047"},{"key":"2025081709413035000_6.2.160.4","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000208408.98482.99"},{"key":"2025081709413035000_6.2.160.5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40263-019-00608-4","article-title":"Tranexamic acid in cerebral hemorrhage: a meta-analysis and systematic review","volume":"33","author":"Hu","year":"2019","journal-title":"CNS Drugs"},{"key":"2025081709413035000_6.2.160.6","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"key":"2025081709413035000_6.2.160.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707534"},{"key":"2025081709413035000_6.2.160.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042991"},{"key":"2025081709413035000_6.2.160.9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2016.1218","article-title":"Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage","volume":"73","author":"Boulouis","year":"2016","journal-title":"JAMA Neurol"},{"key":"2025081709413035000_6.2.160.10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.0000000000004210","article-title":"Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion","volume":"89","author":"Morotti","year":"2017","journal-title":"Neurology"},{"key":"2025081709413035000_6.2.160.11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/WNL.0000000000010660","article-title":"Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome: a meta-analysis","volume":"95","author":"Morotti","year":"2020","journal-title":"Neurology"},{"key":"2025081709413035000_6.2.160.12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1148\/radiol.2017162839","article-title":"Multiphase CT angiography improves prediction of intracerebral hemorrhage expansion","volume":"285","author":"Rodriguez-Luna","year":"2017","journal-title":"Radiology"},{"key":"2025081709413035000_6.2.160.13","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3338"},{"key":"2025081709413035000_6.2.160.14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","article-title":"Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data","volume":"17","author":"Al-Shahi Salman","year":"2018","journal-title":"Lancet Neurol"},{"key":"2025081709413035000_6.2.160.15","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/STROKEAHA.118.024347","article-title":"Meta-analysis of accuracy of the spot sign for predicting hematoma growth and clinical outcomes","volume":"50","author":"Phan","year":"2019","journal-title":"Stroke"},{"key":"2025081709413035000_6.2.160.16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1747493017694394","article-title":"Tranexamic acid for acute intracerebral hemorrhage growth predicted by spot sign trial: rationale and design","volume":"12","author":"Liu","year":"2017","journal-title":"Int J Stroke"},{"key":"2025081709413035000_6.2.160.17","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100007782"},{"key":"2025081709413035000_6.2.160.18","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.009185"},{"key":"2025081709413035000_6.2.160.19","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013186"},{"key":"2025081709413035000_6.2.160.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.8.1304"},{"key":"2025081709413035000_6.2.160.21","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000433"},{"key":"2025081709413035000_6.2.160.22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","article-title":"Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"19","author":"Meretoja","year":"2020","journal-title":"Lancet Neurol"},{"key":"2025081709413035000_6.2.160.23","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2636","article-title":"Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the spotlight and STOP-IT randomized clinical trials","author":"Gladstone","year":"2019","journal-title":"JAMA Neurol"},{"key":"2025081709413035000_6.2.160.24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/STROKEAHA.119.026128","article-title":"Noncontrast computed tomography signs as predictors of hematoma expansion, clinical outcome, and response to tranexamic acid in acute intracerebral hemorrhage","volume":"51","author":"Law","year":"2020","journal-title":"Stroke"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2021-000942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:41:40Z","timestamp":1755448900000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2021-000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6,28]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/svn-2021-000942"],"URL":"https:\/\/doi.org\/10.1136\/svn-2021-000942","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}